The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series.

Autoimmune thyroid diseases Autoimmune thyroiditis Celiac disease Chronic autoimmune gastritis Graves' diseases Graves' ophthalmopathy Multiple sclerosis Polymyalgia rheumatica Rheumatoid arthritis Sarcoidosis Sjogren disease Systemic lupus erythematosus Type 1 diabetes (type 1) Vitiligo

Journal

Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 15 10 2018
accepted: 20 10 2018
pubmed: 15 1 2019
medline: 9 4 2019
entrez: 15 1 2019
Statut: ppublish

Résumé

Graves' disease (GD) and autoimmune thyroiditis (AT) are the two main clinical presentations of AITD, and their clinical hallmarks are thyrotoxicosis and hypothyroidism, respectively. GD, and AT, can be associated with other organ specific, or systemic autoimmune diseases in the same patient. However discordant results have been reported in the literature about the possible associations. Here, we review the association of GD and other autoimmune syndromes. Furthermore, we report the results of our prospective study that investigated the prevalence of other autoimmune disorders in 3209 GD patients (984 with Graves' ophthalmopathy), with respect to 1069 healthy controls, or 1069 patients with AT, or 1069 with multinodular goiter (matched by age, gender, coming from the same area, with a similar iodine intake). On the whole, 16.7% of GD patients had another associated autoimmune disease; and the most frequently observed were: vitiligo (2.6%), chronic autoimmune gastritis (2.4%), rheumatoid arthritis (1.9%), polymyalgia rheumatica (1.3%), multiple sclerosis (0.3%), celiac disease (1.1%), diabetes (type 1) (0.9%), systemic lupus erythematosus and sarcoidosis (<0.1%), Sjogren disease (0.8%). Moreover, 1.5% patients with GD had three associated autoimmune disorders. Interestingly, patients with Graves' ophthalmopathy (GO) had another autoimmmune disorder more frequently (18.9%), with respect to GD patients without GO (15.6%). However the pattern of the associated autoimmune disorders in GD was not significantly different from that observed in AT patients. In conclusion, we suggest GD patients who are still sick, or who develop new unspecific symptoms (even if during an appropriate treatment of hyperthyroidism) should be appropriately screened for the presence of other autoimmune disorders.

Identifiants

pubmed: 30639646
pii: S1568-9972(19)30006-0
doi: 10.1016/j.autrev.2018.10.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-292

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Silvia Martina Ferrari (SM)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.

Poupak Fallahi (P)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.

Ilaria Ruffilli (I)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.

Giusy Elia (G)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.

Francesca Ragusa (F)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy.

Salvatore Benvenga (S)

Department of Clinical and Experimental Medicine, University of Messina, Italy; Master Program on Childhood, Adolescent and Women's Endocrine Health, University of Messina, Italy; Interdepartmental Program of Molecular and Clinical Endocrinology and Women's Endocrine Health, Azienda Ospedaliera Universitaria Policlinico 'G. Martino', Messina I-98125, Italy.

Alessandro Antonelli (A)

Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, Pisa 56126, Italy. Electronic address: alessandro.antonelli@med.unipi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH